Profile of:

Denis Poddubnyy


Full name: Denis Poddubnyy

Current country: Germany

Membership level: Full

Type of membership: EC

Number of publications: 12

Relation of α 2-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/33317138/

The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study (2020)
https://pubmed.ncbi.nlm.nih.gov/33281952/

Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/33053191/

Treat-to-target strategy with secukinumab as a first-line biological disease modifying anti-rheumatic drug compared to standard-of-care treatment in patients with active axial spondyloarthritis: protocol for a randomised open-label phase III study, AScalate (2020)
https://pubmed.ncbi.nlm.nih.gov/32998926/

The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study (2020)
https://pubmed.ncbi.nlm.nih.gov/32912264/

Comparison of an online self-referral tool with a physician-based referral strategy for early recognition of patients with a high probability of axial spa (2020)
https://pubmed.ncbi.nlm.nih.gov/32911279/

Patient-reported Impact of Axial Spondyloarthritis on Working Life: Results from the EMAS survey (2020)
https://pubmed.ncbi.nlm.nih.gov/32813333/

Assessment of radiographic sacroiliitis in anteroposterior lumbar vs conventional pelvic radiographs in axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/32710108/

Treatment of Axial Spondyloarthritis: What Does the Future Hold? (2020)
https://pubmed.ncbi.nlm.nih.gov/32691259/

Clinical and imaging characteristics of osteitis condensans ilii as compared with axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/32447391/

IgA antibodies against CD74 are associated with structural damage in the axial skeleton in patients with axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/32242816/

Axial spondyloarthritis (2017)
https://pubmed.ncbi.nlm.nih.gov/28110981/